• 1
    Madalinska JB, Essink-Bot ML, De Koning HJ, Kirkels WJ, Van Der Maas PJ, Schroder FH. Health-related quality of life in patients with screen-detected versus clinically diagnosed prostate cancer preceding primary treatment. Prostate 2001; 46: 8797
  • 2
    Schapira MM, Lawrence WF, Katz DA, McAuliffe TL, Nattinger AB. Effect of treatment on quality of life among men with clinically localized prostate cancer. Med Care 2001; 39: 24353
  • 3
    Talcott JA, Rieker P, Clark JA et al. Patient-reported symptoms after primary therapy for early prostate cancer. results of a prospective cohort study. J Clin Oncol 1998; 16: 27583
  • 4
    Garssen B, Goodkin K. On the role of immunological factors as mediators between psychosocial factors and cancer progression. Psychiatry Res 1999; 85: 5161
  • 5
    Aalto AM, Uutela A, Aro AR. Health related quality of life among insulin-dependent diabetics: disease-related and psychosocial correlates. Patient Educ Couns 1997; 30: 21525
  • 6
    Cotton SP, Levine EG, Fitzpatrick CM, Dold KH, Targ E. Exploring the relationships among spiritual well- being, quality of life, and psychological adjustment in women with breast cancer. Psychooncology 1999; 8: 42938
  • 7
    Shapiro SL, Lopez AM, Schwartz GE et al. Quality of life and breast cancer: relationship to psychosocial variables. J Clin Psychol 2001; 57: 50119
  • 8
    Eton DT, Lepore SJ, Helgeson VS. Early quality of life in patients with localized prostate carcinoma: an examination of treatment-related, demographic, and psychosocial factors. Cancer 2001; 92: 14519
  • 9
    Westerlaak JM, Kropman JA, Colaris JWH. Job employment hierarchy. Nijmegen Institute Applied Social Sciences, 1990: 1 – 34
  • 10
    Visser A, Breemhaar B, Kleijnen JG. Social desirability and program evaluation in health care. Impact Assessmt Bull 1989; 7: 99112
  • 11
    Aaronson NK, Ahmedzai S, Bergman B et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85: 36576
  • 12
    Barry MJ, Fowler FJ Jr, O'Leary MP et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol 1992; 148: 154957
  • 13
    Vierhout ME. Measurement of undesirable urine loss in women. Ned Tijdschr Geneeskd 1990; 134: 183740
  • 14
    Derogatis LR, Kourlesis SM. An approach to evaluation of sexual problems in the cancer patient. CA Cancer J Clin 1981; 31: 4650
  • 15
    Vroege JA. Questions on Sexual Functioning in Pharmocological Studies. Leiden: Department of Psychology, 1996
  • 16
    Schreurs PJG, Van De Willigen G, De Tellegen B. Utrecht Coping List (UCL); a manual. Lisse, Swets and Zeitlinger, 1988
  • 17
    McNair DM, Lorr M, Droppleman LF. Profile of Mood States (POMS). 2nd ed. San Diego, CA: Educational and Industrial Testing Service, 1988
  • 18
    Horowitz M, Wilner N, Alvarrz W. Impact of Event Scale: a measure of subjective stress. Psychomsom Med 1979; 41: 20918
  • 19
    Bleiker EMA, Ploeg HM, Hendriks JHCL, Leer JWH, Kleijn WC. Rationality, emotional expression and control: psychometric characteristics of a questionnaire for research in psycho-oncology. J Psychom Res 1993; 37: 86172
  • 20
    Sarason I, Levine HM, Basham RB, Sarason BR. Assessing social support: the Social Support Questionnaire. J Pers Soc Psychol 1983; 44: 12739
  • 21
    Sarason IG, Johnson JH, Siegel JM. Assessing the impact of life changes; development of the Life Experience Survey. J Cons Clin Psych 1978; 46: 93246
  • 22
    Saigal CS, Gornbein J, Nease R, Litwin MS. Predictors of utilities for health states in early stage prostate cancer. J Urol 2001; 166: 9426
  • 23
    Penson DF, Stoddard ML, Pasta DJ, Lubeck DP, Flanders SC, Litwin MS. The association between socioeconomic status, health insurance coverage, and quality of life in men with prostate cancer. J Clin Epidemiol 2001; 54: 3508
  • 24
    Lilleby W, Fossa SD, Waehre HR, Olsen DR. Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy. Int J Radiat Oncol Biol Phys 1999; 43: 73543
  • 25
    McCammon KA, Kolm P, Main B, Schellhammer PF. Comparative quality-of-life analysis after radical prostatectomy or external beam radiation for localized prostate cancer. Urology 1999; 54: 50916
  • 26
    Potosky AL, Legler J, Albertsen PC et al. Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the prostate cancer outcomes study. J Natl Cancer Inst 2000; 92: 158292
  • 27
    Litwin MS, Fitzpatrick JM, Fossa SD, Newling DW. Defining an international research agenda for quality of life in men with prostate cancer. Prostate 1999; 41: 5867
  • 28
    Macdonagh R. Quality of life and its assessment in urology. Br J Urol 1996; 78: 48596